Ad
In this article
- GOOGL
Follow your favorite stocksCREATE FREE ACCOUNTSundar Pichai, chief executive officer of Alphabet Inc., during a visit to the Google for Startups campus in Warsaw, Poland, on Thursday, Feb. 13, 2025. The EU has established a reputation globally for its aggressive regulation of major technology companies, including the likes of Apple and Google over antitrust concerns. Photographer: Damian Lemanski/Bloomberg via Getty ImagesDamian Lemanski | Bloomberg | Getty Images
The U.S. government’s remedies trial in the Google antitrust case regarding its advertising tech is scheduled to begin on Sept. 22, according to civil hearing minutes released Friday.
Last month, U.S. District Judge Leonie Brinkema in Alexandria, Virginia, said Google was liable for “willfully acquiring and maintaining monopoly power,” ruling that Google held illegal monopolies in online advertising markets due to its position between ad buyers and sellers.
That followed an August ruling that Google has held a monopoly in its core market of internet search, the most-significant antitrust ruling in the tech industry since the case against Microsoft more than 20 years ago. The remedies trial for that case began last month in Washington, D.C.
Google is in a unique position as it tries to not only defend itself from antitrust allegations in court but also stay ahead of increasing competition in the generative AI market, from startups like Microsoft-backed OpenAI, Amazon-backed Anthropic and Perplexity, which compete directly with its search business.
This is breaking news. Please refresh for updates.
Ad
SomaDerm, SomaDerm CBD, SomaDerm AWE (by New U Life).